Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Karen Tubridy Net Worth & Insider Trades

Karen Tubridy - Chief Development Officer, Eleven Biotherapeutics, Inc

As of July 12, 2016

What is Karen Tubridy's Net Worth?

The current estimated net worth of Eleven Biotherapeutics, Inc's Chief Development Officer, Karen Tubridy, is estimated to be about $203.72K . Karen Tubridy owns about 32,753 units of Eleven Biotherapeutics, Inc common stock. In the last year at Eleven Biotherapeutics, Inc, Karen Tubridy has sold an estimated value of $21.71K worth.

What is Karen Tubridy's Past Insider Trading?

Karen Tubridy's largest sale order was 4,427 units , worth over $12.62K on December 30, 2015. In total, Karen Tubridy has made about 7 transactions over a year of their time at Eleven Biotherapeutics, Inc. Karen Tubridy usually trades in June, with the busiest year in 2016. The most recent transaction was a sale order of 4,372 units , worth over $9.09K on June 29, 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Karen Tubridy

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Karen Tubridy's' Mailing Address?

  • Mailing address is Eleven Biotherapeutics, Inc. 215 First Street, Suite 400 Cambridge MA 02142 MA

What are Eleven Biotherapeutics, Inc's Past Insider Trades?

Eleven Biotherapeutics, Inc's most recent insider trade came on February 16, 2017 by John J McCabe who sold 1,399 units worth $2.94K . In the last 3 years, insiders at Eleven Biotherapeutics, Inc have sold an estimated value of $9.03M and bought an estimated value of $5.99M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Partnership Limited Investment Super Jafco V,  Abbie Celniker, Director,  and John J McCabe, Chief Financial Officer .

Eleven Biotherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...